Skip to main content

BROWN, LISLE/CUMMINGS, INC.

Position in NVO — Novo Nordisk A S

CIK 14745 PROVIDENCE, RI

Position in NVO

as of Mar 31, 2026 · filed Apr 20, 2026
Position Value
$2,175,747
-$831,006 QoQ
Shares Held
59,204
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BROWN, LISLE/CUMMINGS, INC. holds $31,214,852 across 14 Drug Manufacturers - General names. NVO ranks #6 (7.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NVO
Novo Nordisk A S
This page
59,204 $2,175,747

All Filings in NVO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,175,747 59,204
2025-12-31 $3,006,753 59,095
2025-09-30 $3,045,457 54,883
2025-06-30 $3,868,847 56,054
2025-03-31 $3,883,709 55,929
2024-12-31 $4,202,765 48,858
2024-09-30 $5,976,718 50,195
2024-06-30 $6,137,106 42,995
2024-03-31 $5,657,946 44,065
2023-12-31 $4,581,800 44,290
2023-09-30 $3,391,152 37,290
2023-06-30 $2,717,934 16,795
2023-03-31 $2,706,971 17,010
2022-12-31 $2,804,921 20,725
2022-09-30 $2,064,831 20,725
2022-06-30 $2,323,315 20,850
2022-03-31 $2,340,378 21,075
2021-12-31 $2,091,600 18,675